Home › Compare › ZSANQ vs SCHD

ZSANQ vs SCHD: Dividend Comparison 2026

ZSANQ yields 1000000.00% · SCHD yields 3.46%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZSANQ wins by $4.7683925249533696e+36M in total portfolio value
10 years
ZSANQ
ZSANQ
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.7683925249533696e+36M
Annual income
$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00
Full ZSANQ calculator →
SCHD
Schwab U.S. Dividend Equity ETF
● Live price
3.46%
Share price
$30.48
Annual div
$1.06
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.0K
Annual income
$425.95
Full SCHD calculator →

Portfolio growth — ZSANQ vs SCHD

📍 ZSANQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZSANQSCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZSANQ + SCHD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ZSANQ pays
SCHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZSANQ
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr
SCHD
Annual income on $10K today (after 15% tax)
$294.40/yr
After 10yr DRIP, annual income (after tax)
$362.06/yr
At 15% tax rate, ZSANQ beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZSANQ + SCHD for your $10,000?

ZSANQ: 50%SCHD: 50%
100% SCHD50/50100% ZSANQ
Portfolio after 10yr
$2.3841962624766848e+36M
Annual income
$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.98%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZSANQ buys
0
SCHD buys
3
PoliticianChamberTickerTypeAmountDate
Virginia Foxx🏢 House$SCHD▼ Sell$50,001 - $100,0002023-03-08
Steve Cohen🏢 House$SCHD▲ Buy$50,001 - $100,0002022-07-29
Hakeem S. Jeffries🏢 House$SCHD▲ Buy$15,001 - $50,0002021-04-12
Mikie Sherrill🏢 House$SCHD▲ Buy$100,001 - $250,0002020-02-21
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZSANQSCHD
Forward yield1000000.00% ✓3.46%
Annual dividend / share$2.00 ✓$1.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.7683925249533696e+36M$29.0K ✓
Annual income after 10y$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓$425.95
Total dividends collected$4.7683311610149396e+36M ✓$3.9K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: ZSANQ vs SCHD ($10,000, DRIP)

YearZSANQ PortfolioZSANQ Income/yrSCHD PortfolioSCHD Income/yrGap
1← crossover$100,010,700$100,000,000.00$11,226$346.36+$100.00M → ZSANQ
2$934,786,450,701$934,679,439,252.34$12,572$357.38+$934786.44M → ZSANQ
3$8,165,787,108,578,292$8,164,786,887,076,042.00$14,046$367.84+$8165787108.56M → ZSANQ
4$66,665,884,190,957,650,000$66,657,146,798,751,470,000.00$15,660$377.73+$66665884190957.63M → ZSANQ
5$508,662,171,058,048,100,000,000$508,590,838,561,963,700,000,000.00$17,425$387.07+$508662171058048128.00M → ZSANQ
6$3,627,235,248,428,489,700,000,000,000$3,626,690,979,905,457,600,000,000,000.00$19,354$395.86+$3.62723524842849e+21M → ZSANQ
7$24,173,681,159,150,610,000,000,000,000,000$24,169,800,017,434,790,000,000,000,000,000.00$21,461$404.13+$2.417368115915061e+25M → ZSANQ
8$150,567,402,861,454,640,000,000,000,000,000,000$150,541,537,022,614,370,000,000,000,000,000,000.00$23,762$411.89+$1.5056740286145463e+29M → ZSANQ
9$876,477,100,281,847,600,000,000,000,000,000,000,000$876,315,993,160,785,800,000,000,000,000,000,000,000.00$26,272$419.15+$8.764771002818475e+32M → ZSANQ
10$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$29,010$425.95+$4.7683925249533696e+36M → ZSANQ

ZSANQ vs SCHD: Complete Analysis 2026

ZSANQ — Stock

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. On June 1, 2022, Zosano Pharma Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Full ZSANQ Calculator →

SCHD — ETF

The fund’s goal is to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100 Index.

Full SCHD Calculator →
📬

Get this ZSANQ vs SCHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZSANQ vs JEPIZSANQ vs OZSANQ vs KOZSANQ vs MAINZSANQ vs VYMZSANQ vs DGROZSANQ vs VIGZSANQ vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.